postmenopausal women

Related by string. Postmenopausal women * post menopausal . Postmenopausal . Post Menopausal : shunning postmenopausal hormone . postmenopausal osteoporosis . postmenopausal hormone therapy . Postmenopausal Osteoporosis . obese postmenopausal / womens . WOMEN . Womens . WOMENS . Wo Men : Designing Women . Concerned Women . WOMEN 'S WORLD CUP . Women Wear . Battered Women Shelter * *

Related by context. All words. (Click for frequent words.) 79 post menopausal 75 premenopausal women 74 postmenopausal 70 pre menopausal 66 premenopausal 64 menopausal women 63 perimenopausal women 62 calcium supplementation 62 tibolone 62 menopausal hormone therapy 61 endometrial cancer 61 estrogen therapy 61 postmenopausal hormone therapy 61 lipid lowering therapy 61 calcium supplements 61 vitamin D supplementation 61 randomized clinical 61 dose aspirin 60 oral bisphosphonates 60 menopausal symptoms 60 premenopausal breast cancer 60 invasive breast cancer 60 tamoxifen 60 calcium intake 60 postmenopausal breast cancer 60 hormone therapy 60 cardiovascular mortality 60 anastrozole 60 randomized controlled trials 60 teriparatide 59 prospective cohort 59 bisphosphonate therapy 59 folate supplementation 59 randomized clinical trials 59 postmenopausal osteoporosis 59 colorectal adenomas 59 knee osteoarthritis 59 Swedish Mammography Cohort 59 hormone therapy estrogen 59 substudy 59 statin 59 osteoporosis 59 screening mammography 59 multicenter study 58 nulliparous women 58 statin therapy 58 bisphosphonate 58 observational study 58 zoledronic acid 58 lasofoxifene 58 hip BMD 58 vertebral fracture 58 dietary calcium intake 58 statins 58 Framingham Offspring Study 58 folate intake 58 raloxifene 58 randomized controlled trial 58 subclinical hypothyroidism 58 plus progestin 58 hypogonadal men 58 Digital Mammographic Imaging 58 letrozole 57 placebo controlled clinical 57 meta analysis 57 CARDIA 57 antihypertensive therapy 57 Netherlands Cohort Study 57 vasomotor symptoms 57 osteoporotic fractures 57 estrogen progestin therapy 57 hormonal therapy 57 venous thromboembolism 57 magnesium intake 57 testosterone supplementation 57 metformin 57 nonpregnant women 57 Communities ARIC study 57 severe psoriasis 57 Intrinsa 57 observational studies 57 bone mineral 57 GnRH agonists 57 randomized trials 57 anovulatory infertility 57 Health Initiative WHI 57 osteoporotic fracture 57 Prostate Cancer Prevention 57 vitamin D supplements 57 thiazide diuretics 56 DMPA 56 tamoxifen therapy 56 endometrial hyperplasia 56 obese adolescents 56 oophorectomy 56 strontium ranelate 56 estrogen progestin 56 ezetimibe simvastatin 56 alendronate 56 androgen deficiency 56 Vitamin D supplements 56 rosuvastatin 56 hydroxyvitamin D levels 56 hot flashes 56 nonvertebral fracture 56 bisphosphonates 56 nonvertebral fractures 56 colorectal cancer 56 Postmenopausal Women 56 femoral neck BMD 56 undergone hysterectomy 56 Calcium intake 56 WHI 56 oral contraceptives 56 beta carotene supplements 56 randomized 56 dose oral contraceptives 56 Prostate Lung Colorectal 56 estrogen pills 56 estrogen 56 randomized controlled clinical 56 NSAIDs 56 vaginal atrophy 56 hip fractures 55 estradiol 55 osteopenia 55 ischemic stroke 55 recurrent VTE 55 postmenopausal osteoporotic women 55 ATACAND 55 longitudinal cohort study 55 Premenopausal women 55 polycystic ovary syndrome PCOS 55 obese postmenopausal 55 HF ACTION 55 dietary fat 55 Health Initiative Observational 55 Young Adults CARDIA 55 DAPT 55 breast cancer recurrence 55 localized prostate cancer 55 coronary heart 55 randomized controlled 55 adjuvant therapy 55 pioglitazone 55 dutasteride 55 hormone therapy HT 55 glycemic diet 55 MetS 55 cilostazol 55 Clinical Endocrinology & 55 lobular cancer 55 conjugated equine estrogen 55 vitamin D 55 hip fracture 55 spontaneous preterm delivery 55 beta carotene supplementation 55 adjuvant chemotherapy 55 knee OA 55 hormone receptor positive 55 mammographic density 55 CLA supplementation 54 VADT 54 Ovarian Cancer Screening 54 androgen deprivation therapy 54 dysglycemia 54 osteoporosis osteopenia 54 lipid lowering medications 54 homocysteine levels 54 dietary intakes 54 vitamin D intake 54 ovulatory infertility 54 NHANES III 54 colorectal adenoma 54 Professionals Follow 54 rosiglitazone 54 pregabalin 54 NSAID 54 treat menopausal symptoms 54 alendronate Fosamax 54 adalimumab 54 bone density 54 aromatase inhibitor 54 bilateral oophorectomy 54 beta blocker therapy 54 carotid atherosclerosis 54 Screening Trial 54 fragility fractures 54 BMD measurements 54 retrospective cohort study 54 acrylamide intake 54 atypical fractures 54 exemestane 54 mycophenolate mofetil 54 cholesterol lowering medication 54 sedentary postmenopausal 54 mild gestational diabetes 54 dysmenorrhea 54 vitamin E 54 tricyclic antidepressants 54 Prospective Investigation 54 soy isoflavones 54 dietary calcium 54 intravenous bisphosphonates 54 dietary questionnaires 54 thromboprophylaxis 54 raloxifene Evista 54 underwent bariatric surgery 54 cerebral microbleeds 54 cardiovascular disease 54 cardiovascular disease CVD 54 folic acid supplementation 54 Osteoporotic Fractures 54 macrovascular disease 54 hypercholesterolaemia 54 multivitamin supplements 54 trials RCTs 54 symptomatic fibroids 53 INTERHEART study 53 therapy HRT 53 placebo controlled trials 53 aromatase inhibitors AIs 53 hsCRP levels 53 lignan intake 53 symptomatic BPH 53 liver transplant recipients 53 hypertensive patients 53 arzoxifene 53 ARIMIDEX 53 Screening Trial DMIST 53 adenoma 53 folic acid supplements 53 Dietary Modification Trial 53 Nutrition EPIC 53 colorectal neoplasia 53 cognitive function 53 breast cancers 53 CARDIA study 53 risedronate 53 undergone radical prostatectomy 53 candesartan 53 Femara letrozole 53 HYVET 53 nonmelanoma skin cancer 53 selenium supplements 53 estrogen progestin combination 53 ibandronate 53 nondiabetic 53 aldosterone antagonist 53 haemorrhagic stroke 53 serum cholesterol 53 HNSCC 53 placebo controlled 53 Hormone therapy 53 index BMI 53 chronic prostatitis 53 multicenter 53 AVANDIA 53 MMSE scores 53 postmenopausal hormone 53 oral bisphosphonate 53 folic acid supplement 53 epithelial ovarian cancer 53 glitazones 53 parous women 53 lobular breast cancer 53 NATRECOR R 53 Wisconsin Sleep Cohort 53 ginkgo biloba extract 53 Femara 53 normotensive 53 retrospective cohort 53 menopause 53 APTIVUS r 53 folic acid 53 BRCA1 mutations 53 serum vitamin D 53 BRCA2 mutations 53 adenoma recurrence 53 Subgroup analyzes 53 randomized placebo controlled 53 valproate 53 bisphosphonate drugs 53 adjuvant endocrine therapy 53 antihypertensive medications 53 subclinical atherosclerosis 53 plasma folate 53 XGEVA 53 estrogen receptor negative 53 mixed hyperlipidemia 53 Zometa 53 Atherosclerosis MESA 53 polyp recurrence 53 abnormal mammograms 53 mineral density 53 Hormone supplements 53 calcium intakes 53 adiponectin levels 52 metastatic breast cancer 52 modifiable risk 52 elevated CRP 52 T1DM 52 atorvastatin Lipitor 52 osteopenic 52 SSRIs 52 synthetic progestin 52 myocardial infarction MI 52 gallstone disease 52 lumbar spine BMD 52 lipid lowering drugs 52 juvenile idiopathic arthritis 52 dietary intake 52 postmenopausal hormones 52 bazedoxifene 52 CVD mortality 52 thromboembolic events 52 longitudinal study 52 hemodialysis patients 52 Calcium vitamin D 52 hypocaloric diet 52 coronary artery calcium 52 dyslipidemic patients 52 Wactawski Wende 52 RRMS patients 52 sunitinib malate 52 ACTOS 52 Vitamin D supplementation 52 tamsulosin 52 valsartan 52 adolescents 52 selenium intake 52 elevated triglyceride levels 52 calcium vitamin D 52 endometriosis ovarian cysts 52 solifenacin 52 paclitaxel eluting stents 52 slow metabolizers 52 antioxidant supplements 52 Alendronate 52 oral contraceptive pills 52 Postmenopausal women 52 spine fractures 52 nonfatal MI 52 breast carcinoma 52 ARIXTRA 52 venous thrombosis 52 endometrial carcinoma 52 dietary antioxidants 52 HER2 positive breast cancer 52 odanacatib 52 DEXA scan 52 dyslipidemia 52 aromatase inhibitor therapy 52 supplementation 52 serum IGF 52 selenium supplementation 52 TZDs 52 coronary artery calcification 52 TZD 52 thiazolidinediones 52 donepezil 52 THIS STUDY 52 Multi Ethnic Study 52 narcolepsy cataplexy 52 advanced adenomas 52 irregular menstrual cycles 52 vulvovaginal atrophy 52 Osteopenia 52 ticagrelor 52 osteoporotic 52 atherothrombotic events 52 medroxyprogesterone acetate 52 preoperative chemotherapy 52 androgen therapy 52 calcium metabolism 52 thromboembolic 52 phosphate binders 52 Study AREDS 52 inflammatory polyarthritis 52 denosumab 52 mammography screening 52 Leitzmann 52 bronchial thermoplasty 52 hormone pills 52 placebo 52 grade glioma 52 biologic therapy 52 BARI 2D 52 folate 52 IV bisphosphonates 52 olaparib 52 glucocorticoid induced osteoporosis 52 placebo controlled clinical trials 52 androgen deprivation 52 spontaneous preterm birth 52 hydroxychloroquine 52 Natural S equol 52 rivaroxaban 51 ARCOXIA 51 PLCO 51 vitamin D insufficiency 51 CYPHER Stent 51 VTE 51 ExTRACT TIMI 51 progestin pills 51 artery calcification 51 vertebral fractures 51 nondepressed 51 Estrogen therapy 51 dietary glycemic index 51 adjuvant radiotherapy 51 endometrial cancers 51 contralateral breast cancer 51 β blockers 51 hypercholesterolemia 51 prostate cancer PCa 51 iodine intake 51 rosuvastatin #mg 51 vegetable intake 51 dabigatran 51 cognitively normal 51 systolic hypertension 51 advanced adenoma 51 COPAXONE R 51 N telopeptide 51 microalbuminuria 51 nonmelanoma skin cancers 51 breast tenderness 51 undergone hysterectomies 51 serum uric acid 51 posaconazole 51 Calcium supplementation 51 vandetanib 51 paricalcitol 51 Reclast 51 primary hypercholesterolemia 51 Aclasta 51 pitavastatin 51 severe menopausal symptoms 51 dietary patterns 51 TRILIPIX 51 Ovarian PLCO Cancer 51 Dabigatran 51 serum lipid levels 51 chlamydial infection 51 LNG IUS 51 plasma homocysteine levels 51 Epidemiologic studies 51 progestin therapy 51 vitamin B# supplements 51 CYP#D# inhibitor 51 placebo controlled studies 51 antidepressant therapy 51 phytoestrogen intake 51 RBC folate 51 antiarrhythmic drug 51 venous thromboembolic events 51 SSRI antidepressants 51 Postmenopausal 51 vitamin D deficiency 51 metastatic renal cell carcinoma 51 knee osteoarthritis OA 51 stable angina 51 fragility fracture 51 double blind placebo 51 lipid lowering medication 51 prospective randomized 51 cardiovascular 51 patients 51 fluvastatin 51 phytoestrogen 51 migraine sufferers 51 chemoprevention trials 51 proliferative diabetic retinopathy 51 mg calcium 51 prospective multicentre 51 ziprasidone 51 ischemic strokes 51 nondiabetic patients 51 colorectal cancer incidence 51 NSTE ACS 51 antihypertensive drugs 51 clopidogrel Plavix 51 CaP 51 basal cell nevus syndrome 51 cirrhotic patients 51 rosuvastatin Crestor 51 cardiovascular morbidity 51 fluoxetine Prozac 51 cisplatin chemotherapy 51 Women Ischemia Syndrome 51 bevacizumab 51 atypical subtrochanteric femur fractures 51 metastatic prostate cancer 51 statin medications 51 FOSRENOL R 51 CHD mortality 51 vitamin D intakes 51 neurocognitive function 51 loop diuretics 51 brain shrinkage 51 ticlopidine 51 RE LY 51 vitamin D2 51 Memory Study WHIMS 51 kidney transplant recipients 51 clopidogrel 51 thromboembolic disease 51 sulphonylureas 51 BRCA2 mutation carriers 51 endometrial kidney 51 uncomplicated pregnancies 51 invasive bladder 51 aldosterone antagonists 51 Carotid Revascularization Endarterectomy vs. 51 pathologic fractures 51 lowfat diet 51 progestins 51 bazedoxifene conjugated estrogens 51 prospectively randomized 51 ONTARGET 51 carotid stenosis 51 metabolic syndrome 51 dietary folate intake 51 relapsing remitting MS 51 DHA supplementation 51 operable breast cancer 51 HGPIN 51 BRCA1 mutation carriers 51 paroxetine Paxil 51 estrogen progestin pills 51 STRIDE PD 51 Communities ARIC Study 51 recurrent ovarian cancer 51 folic acid intake 51 adrenal function 51 ALLHAT 51 elevated depressive symptoms 51 Fablyn 51 folate deficiency 51 thyroid hormone levels 51 CC genotype 51 subtrochanteric 51 BRCA mutation carriers 51 Ozarelix 51 adjuvant radiation 51 coronary calcification 51 Estradiol 51 preterm delivery 51 Avandia Actos 51 HSDD 51 epidemiological studies 51 mg d 51 lipid abnormalities 51 randomized double 51 eplerenone 51 Ophena TM 51 LUTS 51 PHPT 51 urinary symptoms 51 thromboembolisms 51 fat diets 51 osteoarthritis OA 51 abnormal Pap test 51 PRADAXA 51 perimenopausal 51 vaginal progesterone gel 51 serum testosterone 51 oral contraceptive pill 51 distal colon cancer 51 NAFLD 51 alleviate menopausal symptoms 51 Betaferon ® 50 containing drospirenone 50 antiepileptic drugs AEDs 50 urothelial cancer 50 ductal cancer 50 PSA screening 50 LDL cholesterol levels 50 Teriparatide 50 flavonoid intake 50 fibrates 50 postmenopause 50 mg dose 50 valvulopathy 50 BRCA mutations 50 colon polyps 50 insulin detemir 50 dose clopidogrel 50 patients undergoing CABG 50 Clinical Endocrinology 50 isoflavone supplements 50 atypia 50 flutamide 50 hypercalcemia 50 timepoint 50 postoperative mortality 50 insulin glargine 50 randomized controlled clinical trials 50 ICDs implanted 50 pravastatin 50 rectal cancer 50 gestational hypertension 50 prospective observational 50 serum parathyroid hormone 50 postoperative atrial fibrillation 50 risedronate Actonel 50 SSRI 50 faulty BRCA genes 50 serum folate 50 pravastatin Pravachol 50 Faslodex 50 periprocedural MI 50 Novartis Zometa 50 newer antipsychotics 50 cholesterol lowering drugs 50 Cochrane reviewers 50 entecavir 50 nondrinkers 50 Multiethnic Study 50 osteoarthritis 50 postmenopausal estrogen 50 eptifibatide 50 atypical hyperplasia 50 screening colonoscopy 50 etanercept 50 Prempro pills 50 FASLODEX 50 telmisartan 50 Oral contraceptives 50 hormone receptor negative 50 cholinesterase inhibitor 50 Clinical Nutrition 50 lipid levels 50 antiepileptic drug 50 capecitabine 50 Zocor simvastatin 50 carotid artery stenting 50 herpes zoster vaccine 50 urinary tract symptoms LUTS 50 methotrexate 50 conjugated equine estrogens 50 #mg/day [001] 50 isotretinoin 50 HeFT 50 isoflavones 50 tumor histology 50 relapsed MM 50 Atacand 50 concomitant medications 50 rectal cancers 50 thyroid dysfunction 50 warfarin 50 celecoxib 50 premenstrual syndrome PMS 50 aspirin therapy 50 underwent prostatectomy 50 selegiline 50 anticholinergic drugs 50 subclinical hyperthyroidism 50 HER2 positive cancers 50 protease inhibitor PI 50 progestogen 50 mild cognitive impairment 50 estrogen deficiency 50 temsirolimus 50 macronutrient intake 50 vitamin D inadequacy 50 fat diet 50 clinical trial 50 efalizumab 50 estrogen receptor positive 50 NSCLC 50 intravesical therapy 50 pegylated liposomal doxorubicin 50 octreotide LAR 50 sevelamer 50 myocardial infarction 50 ovarian cancer 50 diuretic chlorthalidone 50 Buijsse 50 abnormal glucose tolerance 50 irritable bowel syndrome IBS 50 simvastatin 50 biochemical recurrence 50 colorectal cancer CRC 50 mineral density BMD 50 letrozole Femara 50 ximelagatran 50 folate supplements 50 glycated hemoglobin levels 50 rimonabant #mg 50 chromium picolinate 50 Protelos 50 antidiabetic medication 50 migraineurs 50 observational cohort study 50 multicenter clinical 50 elevated LDL cholesterol 50 recurrent venous thromboembolism 50 bone density measurements 50 vitamin D supplement 50 benign breast 50 tocilizumab 50 cardiorespiratory fitness 50 antiplatelet therapy 50 AOD# [002] 50 gadobutrol 50 Stenting Trial CREST 50 non aspirin NSAIDs 50 neovascular AMD 50 endogenous estrogen 50 ACCORD Lipid 50 nondiabetics 50 Denosumab 50 menthol smokers 50 telomere lengths 50 nortriptyline 50 prescribed statins 50 Torisel 50 dietary supplementation 50 chlorambucil 50 prostate cancer CaP 50 mIU L 50 phase IIb trial 50 peginterferon 50 peri menopausal women 50 undergoing coronary artery 50 cinacalcet 50 antioxidant supplementation 50 HbA 1c 50 abatacept 50 post menopausal osteoporosis 50 oral contraception 50 Concord grape juice 50 infliximab Remicade 50 Amrubicin 50 dose ionizing radiation 50 neoadjuvant chemotherapy 50 KRAS status 50 ICD implants 50 thiazolidinediones TZDs 50 elevated hsCRP 50 venlafaxine Effexor 50 exemestane Aromasin 50 improves insulin sensitivity 50 gastric cancer 50 diabetes mellitus 50 GnRH agonist 50 tamoxifen raloxifene 50 aripiprazole 50 prospective longitudinal 50 venous thromboembolisms 50 retinal vein occlusion 50 oral antidiabetic medication 50 ACE inhibitors 50 NOLVADEX 50 NATRECOR ® 50 homocysteine concentrations 50 confidence interval #.#-#.# 50 inhaled corticosteroids 50 antigen PSA 50 transdermal estrogen 50 AIM HIGH 50 RE LY ® 50 atrial fibrillation 50 chemopreventive agent 50 cognitive decline 49 RoACTEMRA 49 esophageal squamous cell carcinoma 49 BZA CE 49 placebo controlled Phase 49 nonrandomized 49 VaD 49 angiotensin receptor blockers 49 oropharyngeal cancer 49 #mg/day [002] 49 bezafibrate 49 density BMD 49 PREZISTA r 49 familial hypercholesterolemia 49 Celebrex celecoxib 49 T2DM 49 LYSTEDA 49 PREMPRO 49 RCTs 49 naturally occurring estrogen 49 SORT OUT III 49 endometrial 49 anticonvulsant medications 49 blind placebo controlled 49 depressive symptoms 49 diabetics 49 5-FU/LV 49 inhaled steroids 49 meta analyzes 49 glucocorticoid therapy 49 breast cancer recurrences 49 bone metastasis 49 severe aortic stenosis 49 Edge STudy 49 thyrotropin levels 49 Hydroxyurea 49 antiestrogen 49 vildagliptin 49 Stacy Tessler Lindau 49 APPRAISE 49 pramlintide 49 dietary fiber intake 49 aromatase inhibitors 49 recurrent metastatic 49 endarterectomy 49 prophylactic mastectomy 49 zoledronic acid Zometa 49 Crestor rosuvastatin 49 pyridostigmine 49 screening mammogram 49 typical antipsychotics 49 hypoparathyroidism 49 RE LY trial 49 irbesartan 49 fasting insulin 49 Fosamax Boniva 49 CrCl 49 eribulin 49 hypertensives 49 ruboxistaurin 49 serum phosphate 49 enlarged prostates 49 hypertension diabetes mellitus 49 TRITON TIMI 49 nonalcoholic steatohepatitis NASH 49 Vagifem 49 chlorthalidone 49 EBRT 49 non valvular atrial 49 fibrate 49 Cholesterol Levels SPARCL 49 triglyceride levels 49 bupropion SR 49 hypogonadal 49 EDARBI 49 HbA1c levels 49 atazanavir 49 Xgeva 49 uncontrolled hypertension 49 relapsing remitting multiple sclerosis 49 squamous histology 49 onset atrial fibrillation 49 chemoradiation 49 hormonal contraception 49 pCR 49 ataluren 49 plaque psoriasis 49 rFVIIa 49 Insulin sensitivity 49 leiomyomas 49 BENICAR HCT 49 thrombotic events 49 lumbar spine bone 49 Trandolapril 49 dummy pills 49 ALCL 49 GBA mutations 49 chronic angina 49 prospectively defined 49 antihypertensive medication 49 toremifene 49 glycemic load 49 olmesartan 49 Calcium supplements 49 histologically confirmed 49 thiazide diuretic 49 asymptomatic carotid stenosis 49 dyslipidaemia 49 Exemestane 49 prehypertensive 49 Prostatitis 49 DASH diet 49 ductal breast cancer 49 atypical femur fractures 49 fasting triglyceride levels 49 abiraterone acetate 49 Combination therapy 49 BRCA carriers 49 progestin 49 gemcitabine 49 weekly subcutaneous injections 49 recurrent stroke 49 hormone replacement 49 dual antiplatelet therapy 49 antidiabetic agents 49 thyrotoxicosis 49 oxycodone CR 49 Tamoxifen 49 ACTEMRA TM 49 everolimus eluting stents 49 TYKERB 49 lamotrigine 49 Invasive Breast Cancer 49 probiotic supplementation 49 Dialysis Outcomes 49 imatinib 49 femoral neck fracture 49 Acute Coronary Syndromes ACS 49 heavily pretreated 49 triglyceride concentrations 49 Celecoxib APC trial 49 BRCA gene mutations 49 Kivipelto 49 statin cholesterol lowering 49 EVISTA 49 Atherosclerosis Risk 49 Severe Primary IGFD 49 Osteoarthritis OA 49 DMARD 49 alpha carotene 49 NPH insulin 49 DCCT 49 Bone Mineral Density 49 fenofibrate 49 elagolix 49 CLBP 49 hypothalamic amenorrhea 49 Hormonal therapy 49 oral FTY# 49 Degarelix 49 overactive bladder symptoms 49 undergoing hysterectomy 49 Demark Wahnefried 49 mammographic breast density 49 serum calcium 49 sunitinib 49 epidemiologic studies 49 UKPDS 49 Progestin 49 oestradiol 49 Soy isoflavones 49 Investigative Dermatology 49 pancreatic adenocarcinoma 49 desvenlafaxine succinate 49 ARB telmisartan 49 goserelin 49 ACE inhibitor 49 pioglitazone Actos 49 subgroup analyzes 49 atorvastatin 49 SPIRIT III 49 statins cholesterol lowering 49 OSAHS 49 AGILECT R 49 rheumatoid arthritis RA 49 atherosclerotic disease 49 colorectal liver metastases 49 Baltimore Longitudinal Study 49 chemoradiotherapy 49 ZD# [001] 49 superficial bladder cancer 49 distant metastases 49 nonfasting triglyceride levels 49 uterine cancers 49 venous thromboembolism VTE 49 Ovary removal 49 ICD implantation 49 elevated uric acid 49 HER2 positive metastatic breast 49 coronary artery disease 49 HRQOL 49 noncardiac surgery 49 Velcade bortezomib 49 breastfed infants 49 pegaptanib 49 multicentre randomized 49 genetic variants associated 49 sorafenib Nexavar 49 abdominal ultrasounds 49 perindopril 49 FOSRENOL 49 GH deficient 49 MSI #F 49 anticholinergics 49 multicenter placebo controlled 49 colon tumors 49 DRB1 * 49 colon polyp 49 autoantibody positive 49 NNT = 49 mCRC patients 49 nonfasting triglycerides 49 urinary incontinence 49 relieving menopausal symptoms 49 plasma selenium 49 tiotropium 49 randomized blinded 49 hormone estradiol 49 ovulation induction 49 dietary modification 49 Barrett Esophagus 49 dose oral contraceptive

Back to home page